Jeffrey Perl1, Angelo Karaboyas2, Hal Morgenstern2,3, Ananda Sen4, Hugh C Rayner5, Raymond C Vanholder6, Christian Combe7, Takeshi Hasegawa8,9, Fredric O Finkelstein10, Antonio A Lopes11, Bruce M Robinson2,12, Ronald L Pisoni2, Francesca Tentori2,13. 1. Division of Nephrology, St Michael's Hospital, University of Toronto, Toronto, ON, Canada. 2. Arbor Research Collaborative for Health, Ann Arbor, MI, USA. 3. Departments of Epidemiology and Environmental Health Sciences, School of Public Health, and Department of Urology, Medical School, University of Michigan, Ann Arbor, MI, USA. 4. Department of Biostatistics and Department of Family Medicine, University of Michigan, Ann Arbor, MI, USA. 5. Heart of England NHS Foundation Trust, Birmingham, UK. 6. University Hospital, Ghent, Belgium. 7. Centre Hospitalier Universitaire de Bordeaux and Université de Bordeaux, Bordeaux, France. 8. Department of Innovative Research and Education for Clinicians and Trainees, Fukushima Medical University Hospital, Fukushima, Japan. 9. Division of Nephrology, Showa University Fujigaoka Hospital, Yokohama, Japan. 10. Hospital of St Raphael, Yale University, New Haven, CT, USA. 11. Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, BA, Brazil. 12. Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. 13. Vanderbilt University, Medical Center, Nashville, TN, USA.
Abstract
Background: Cross-sectional health-related quality of life (HR-QOL) measures are associated with mortality in hemodialysis (HD) patients. The impact of changes in HR-QOL on outcomes remains unclear. We describe the association of prior changes in HR-QOL with subsequent mortality among HD patients. Methods: A total of 13 784 patients in the Dialysis Outcomes and Practice Patterns Study had more than one measurement of HR-QOL. The impact of changes between two measurements of the physical (PCS) and mental (MCS) component summary scores of the SF-12 on mortality was estimated with Cox regression. Results: Mean age was 62 years (standard deviation: 14 years); 59% were male and 32% diabetic. Median time between HR-QOL measurements was 12 months [interquartile range (IQR): 11, 14]. Median initial PCS and MCS scores were 37.5 (IQR: 29.4, 46.2) and 46.4 (IQR: 37.2, 54.9); median changes in PCS and MCS scores were -0.2 (IQR: -5.5, 4.7) and -0.1 (IQR: -6.8, 5.9), respectively. The adjusted hazard ratio (HR) for a 5-point decline in HR-QOL score was 1.09 [95% confidence interval (CI): 1.06-1.12] for PCS and 1.05 (95% CI: 1.03-1.08) for MCS. Adjusting for the second QOL score, the change was not associated with mortality: HR = 1.01 (95% CI: 0.98-1.05) for delta PCS and 1.01 (95% CI: 0.98-1.03) for delta MCS. Categorizing the first and second scores as predictors, only the second PCS or MCS score was associated with mortality. Conclusions: In our study, only the most recent HR-QOL score was associated with mortality. Hence, the predictive power of a measurement of HR-QOL is not affected by changes in HR-QOL prior to that measurement; more frequent HR-QOL measurements are needed to improve the prediction of outcomes in HD. Further studies are needed to determine the optimal frequency and appropriate instrument to be used for serial measurements.
Background: Cross-sectional health-related quality of life (HR-QOL) measures are associated with mortality in hemodialysis (HD) patients. The impact of changes in HR-QOL on outcomes remains unclear. We describe the association of prior changes in HR-QOL with subsequent mortality among HDpatients. Methods: A total of 13 784 patients in the Dialysis Outcomes and Practice Patterns Study had more than one measurement of HR-QOL. The impact of changes between two measurements of the physical (PCS) and mental (MCS) component summary scores of the SF-12 on mortality was estimated with Cox regression. Results: Mean age was 62 years (standard deviation: 14 years); 59% were male and 32% diabetic. Median time between HR-QOL measurements was 12 months [interquartile range (IQR): 11, 14]. Median initial PCS and MCS scores were 37.5 (IQR: 29.4, 46.2) and 46.4 (IQR: 37.2, 54.9); median changes in PCS and MCS scores were -0.2 (IQR: -5.5, 4.7) and -0.1 (IQR: -6.8, 5.9), respectively. The adjusted hazard ratio (HR) for a 5-point decline in HR-QOL score was 1.09 [95% confidence interval (CI): 1.06-1.12] for PCS and 1.05 (95% CI: 1.03-1.08) for MCS. Adjusting for the second QOL score, the change was not associated with mortality: HR = 1.01 (95% CI: 0.98-1.05) for delta PCS and 1.01 (95% CI: 0.98-1.03) for delta MCS. Categorizing the first and second scores as predictors, only the second PCS or MCS score was associated with mortality. Conclusions: In our study, only the most recent HR-QOL score was associated with mortality. Hence, the predictive power of a measurement of HR-QOL is not affected by changes in HR-QOL prior to that measurement; more frequent HR-QOL measurements are needed to improve the prediction of outcomes in HD. Further studies are needed to determine the optimal frequency and appropriate instrument to be used for serial measurements.
Authors: Wim L Loosman; Tiny Hoekstra; Sandra van Dijk; Caroline B Terwee; Adriaan Honig; Carl E H Siegert; Friedo W Dekker Journal: Nephrol Dial Transplant Date: 2015-03-31 Impact factor: 5.992
Authors: Rebecca J Muehrer; Dori Schatell; Beth Witten; Ronald Gangnon; Bryan N Becker; R Michael Hofmann Journal: Clin J Am Soc Nephrol Date: 2011-03-10 Impact factor: 8.237
Authors: Ronald L Pisoni; Brenda W Gillespie; David M Dickinson; Kenneth Chen; Michael H Kutner; Robert A Wolfe Journal: Am J Kidney Dis Date: 2004-11 Impact factor: 8.860
Authors: Bruce F Culleton; Michael Walsh; Scott W Klarenbach; Garth Mortis; Narine Scott-Douglas; Robert R Quinn; Marcello Tonelli; Sarah Donnelly; Matthias G Friedrich; Andreas Kumar; Houman Mahallati; Brenda R Hemmelgarn; Braden J Manns Journal: JAMA Date: 2007-09-19 Impact factor: 56.272
Authors: Murilo Guedes; Liz Wallim; Camila R Guetter; Yue Jiao; Vladimir Rigodon; Chance Mysayphonh; Len A Usvyat; Pasqual Barretti; Peter Kotanko; John W Larkin; Franklin W Maddux; Roberto Pecoits-Filho; Thyago Proenca de Moraes Journal: PLoS One Date: 2022-06-24 Impact factor: 3.752
Authors: Friedrich K Port; Hal Morgenstern; Brian A Bieber; Angelo Karaboyas; Keith P McCullough; Francesca Tentori; Ronald L Pisoni; Bruce M Robinson Journal: Nephrol Dial Transplant Date: 2017-04-01 Impact factor: 5.992